RANKL/RANK/OPG: Key Therapeutic Target in Bone Oncology

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|5|3|263-268

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.5, Iss.3, 2008-09, pp. : 263-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mammalian target of rapamycin as a therapeutic target in oncology

By Abraham Robert T   Eng Christina H  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 209-222

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology

By  

Current Pharmaceutical Design, Vol. 12, Iss. 21, 2006-07 ,pp. : 2631-2644

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate signalling in bone: a therapeutic target for osteoporosis?

By Genever P.G.   Skerry T.M.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 2, 2000-04 ,pp. : 207-218

Informa Healthcare

Access to resources Recommend Favorite

TGF-&bgr; Pathway as a Therapeutic Target in Bone Metastases

By  

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1301-1312

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma

By  

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1272-1283

Bentham Science Publishers

Access to resources Recommend Favorite